Bullish & Foolish
Full DERM fundamentals All 466 on the Survival Watch

DERMJourney Medical Corp

Is Journey Medical struggling financially?

Yes, by its own account. Journey Medical told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$218.7M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

31+ mo

Runs out some time after Jan 2029, raising nothing.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$25.6M

÷

Cash burned over the last 12 months

$8.4M

What Journey Medical told the SEC

Company’s 2026 Shelf, or a new registration statement, or in an unregistered, exempt transaction. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. However, as a result of recurring and historical losses, substantial doubt exists about the Company’s ability to continue as a going concern for a period of at least twelve months from the date of issuance of these financial statements. The financial…

Journey Medical Corp, Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 19.4% share-count increase The company issued stock. Each share now owns 16.2% less of the business than a year ago, before any change in the price.
  • Cash burn is narrowing It is spending 47% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt